-
1
-
-
17144388945
-
Infliximab maintenance treatment reduces hospitalizations, surgeries and procedures in fistulizing Crohn's disease
-
Lichstenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128:862-869.
-
(2005)
Gastroenterology
, vol.128
, pp. 862-869
-
-
Lichstenstein, G.R.1
Yan, S.2
Bala, M.3
-
2
-
-
32944461717
-
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
-
Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc. 2006; 63:433-442.
-
(2006)
Gastrointest Endosc
, vol.63
, pp. 433-442
-
-
Rutgeerts, P.1
Diamond, R.H.2
Bala, M.3
-
3
-
-
0032723990
-
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine
-
D'Haens G, Geboes K, Rutgeerts P, et al. Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. Gastrointest Endosc. 1999;50:667-671.
-
(1999)
Gastrointest Endosc
, vol.50
, pp. 667-671
-
-
D'Haens, G.1
Geboes, K.2
Rutgeerts, P.3
-
4
-
-
0028899859
-
Methotrexate for the treatment of Crohn's disease. The North American Crohn's study group investigators
-
Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's study group investigators. N Engl J Med. 1995;332: 292-297.
-
(1995)
N Engl J Med
, vol.332
, pp. 292-297
-
-
Feagan, B.G.1
Rochon, J.2
Fedorak, R.N.3
-
5
-
-
0025322362
-
Glucocorticoid treatment in ileal Crohn's diseae: Relief of symptoms but not of endoscopically viewed inflammation
-
Olaison G, Sjödahl R, Tagesson C. Glucocorticoid treatment in ileal Crohn's diseae: relief of symptoms but not of endoscopically viewed inflammation. Gut. 1990;31:325-328.
-
(1990)
Gut
, vol.31
, pp. 325-328
-
-
Olaison, G.1
Sjödahl, R.2
Tagesson, C.3
-
6
-
-
0034016066
-
Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease
-
Fell JME, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther. 2000;14:281-289.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 281-289
-
-
Fell, J.M.E.1
Paintin, M.2
Arnaud-Battandier, F.3
-
7
-
-
39449085441
-
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: An open randomised trial
-
D'Haens G, Baert F, Van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet. 2008;371:660-667.
-
(2008)
Lancet
, vol.371
, pp. 660-667
-
-
D'Haens, G.1
Baert, F.2
Van Assche, G.3
-
8
-
-
0024517127
-
Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease
-
Kozarek RA, Patterson DJ, Gelfand MD, et al. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Int Med. 1989;110:353-356.
-
(1989)
Ann Int Med
, vol.110
, pp. 353-356
-
-
Kozarek, R.A.1
Patterson, D.J.2
Gelfand, M.D.3
-
9
-
-
33746872693
-
The use of methotrexate is associated with mucosal healing in Crohn's disease
-
Panaccione R. The use of methotrexate is associated with mucosal healing in Crohn's disease. Gastroenterology. 2005;128(suppl):A49.
-
(2005)
Gastroenterology
, vol.128
, Issue.SUPPL.
-
-
Panaccione, R.1
|